Fundraising Fox

Biocytogen

Beijing, CN · 1 known investors

Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs. It provides antibody discovery, humanized mouse models (e.g. B-NDG, immune checkpoint humanized mice), and preclinical pharmacology and CRO services to biopharma clients worldwide.

BiotechDeep TechHealthtech

Investors · 1

Cowin Capital GroupShenzhen · $1.4M – $50M

Competitors · 1

by search overlap
Taconic Biosciences4 shared keywordsTaconic Biosciences provides genetically engineered mouse and rat models, humanized immune system mice, custom model generation, colony management, and in vivo research services. It serves drug discovery and preclinical researchers, offering integrated laboratory animal models and services from model selection through study-ready cohorts.

Companies competing with Biocytogen for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Biocytogen do?
Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs. It provides antibody discovery, humanized mouse models (e.g. B-NDG, immune checkpoint humanized mice), and preclinical pharmacology and CRO services to biopharma clients worldwide.
Who are Biocytogen's investors?
Biocytogen's investors include Cowin Capital Group.
Where is Biocytogen headquartered?
Biocytogen is headquartered in Beijing, CN.